logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 6
  • 1
    Finan, Peter Michael, Dr
    Born in July 1967
    Individual (22 offsprings)
    Officer
    2017-02-24 ~ now
    OF - Director → CIF 0
  • 2
    Sirinakis, Kyparissia Katie
    Born in July 1965
    Individual (10 offsprings)
    Officer
    2023-02-21 ~ now
    OF - Director → CIF 0
  • 3
    Roper, Elizabeth Ann
    Executive born in July 1974
    Individual (16 offsprings)
    Officer
    2017-02-24 ~ 2023-02-21
    OF - Director → CIF 0
  • 4
    Miscampbell, Ian
    Born in March 1962
    Individual (39 offsprings)
    Officer
    2018-03-09 ~ now
    OF - Director → CIF 0
  • 5
    CRT PIONEER GP LIMITED
    07933818
    4 Claridge Court, Lower Kings Road, Berkhamsted, England
    Active Corporate (3 parents, 4 offsprings)
    Person with significant control
    2018-03-09 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 6
    EPIDAREX CAPITAL PARTNERS LIMITED
    - now SC437985 SC625112
    ROCK SPRING VENTURES GP LIMITED - 2014-01-27
    137a, George Street, Edinburgh
    Active Corporate (5 parents, 12 offsprings)
    Person with significant control
    2017-02-24 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
parent relation
Company in focus

ADORX THERAPEUTICS LIMITED

Period: 2017-02-24 ~ now
Company number: SC558719
Registered name
ADORX THERAPEUTICS LIMITED - now
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Administrative Expenses
-112,710 GBP2024-02-29 ~ 2025-02-28
-155,084 GBP2023-03-01 ~ 2024-02-28
Profit/Loss on Ordinary Activities Before Tax
89,415 GBP2024-02-29 ~ 2025-02-28
11,971,761 GBP2023-03-01 ~ 2024-02-28
Profit/Loss
211,002 GBP2024-02-29 ~ 2025-02-28
13,145,448 GBP2023-03-01 ~ 2024-02-28
Debtors
80,710 GBP2025-02-28
3,779,471 GBP2024-02-28
Cash at bank and in hand
4,886,329 GBP2025-02-28
5,435,944 GBP2024-02-28
Current Assets
4,967,039 GBP2025-02-28
9,215,415 GBP2024-02-28
Net Current Assets/Liabilities
4,860,345 GBP2025-02-28
7,849,343 GBP2024-02-28
Equity
Called up share capital
382 GBP2025-02-28
382 GBP2024-02-28
382 GBP2023-02-28
Retained earnings (accumulated losses)
4,859,963 GBP2025-02-28
7,848,961 GBP2024-02-28
5,979,168 GBP2023-02-28
Equity
4,860,345 GBP2025-02-28
7,849,343 GBP2024-02-28
10,703,895 GBP2023-02-28
Share premium
0 GBP2025-02-28
0 GBP2024-02-28
4,724,345 GBP2023-02-28
Profit/Loss
Retained earnings (accumulated losses)
211,002 GBP2024-02-29 ~ 2025-02-28
13,145,448 GBP2023-03-01 ~ 2024-02-28
Dividends Paid
Retained earnings (accumulated losses)
-16,000,000 GBP2023-03-01 ~ 2024-02-28
Dividends Paid
-3,200,000 GBP2024-02-29 ~ 2025-02-28
Audit Fees/Expenses
13,500 GBP2024-02-29 ~ 2025-02-28
12,300 GBP2023-03-01 ~ 2024-02-28
Wages/Salaries
48,000 GBP2024-02-29 ~ 2025-02-28
48,000 GBP2023-03-01 ~ 2024-02-28
Staff Costs/Employee Benefits Expense
53,368 GBP2024-02-29 ~ 2025-02-28
53,239 GBP2023-03-01 ~ 2024-02-28
Director Remuneration
48,000 GBP2024-02-29 ~ 2025-02-28
48,000 GBP2023-03-01 ~ 2024-02-28
Intangible Assets - Gross Cost
Computer software
4,000 GBP2024-02-28
Property, Plant & Equipment - Gross Cost
Computers
3,714 GBP2024-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
3,714 GBP2024-02-28
Property, Plant & Equipment
Computers
0 GBP2025-02-28
0 GBP2024-02-28
Trade Debtors/Trade Receivables
Current
0 GBP2025-02-28
2,574,257 GBP2024-02-28
Amount of corporation tax that is recoverable
Current
70,268 GBP2025-02-28
1,173,687 GBP2024-02-28
Other Debtors
Current
10,442 GBP2025-02-28
31,527 GBP2024-02-28
Trade Creditors/Trade Payables
Current
71,730 GBP2025-02-28
135,972 GBP2024-02-28
Creditors
Current
106,694 GBP2025-02-28
1,366,072 GBP2024-02-28
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
268,532 shares2025-02-28
Par Value of Share
Class 1 ordinary share
0.01 GBP2024-02-29 ~ 2025-02-28
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
211,320 shares2025-02-28
Par Value of Share
Class 2 ordinary share
0.01 GBP2024-02-29 ~ 2025-02-28
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
3,338,590 shares2025-02-28
Par Value of Share
Class 3 ordinary share
0.01 GBP2024-02-29 ~ 2025-02-28
Equity
Called up share capital
382 GBP2025-02-28
382 GBP2024-02-28
Average Number of Employees
02024-02-29 ~ 2025-02-28

  • ADORX THERAPEUTICS LIMITED
    Info
    Registered number SC558719
    137a George Street, Edinburgh EH2 4JY
    PRIVATE LIMITED COMPANY incorporated on 2017-02-24 (9 years 3 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-02-24
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.